Neither Hide Nor Hair: The Difficulty of Identifying Useful Disease Biomarkers

Gastroenterology

Volumn 134, Issue 7, 2008, Pages 2164-2168

  Huett, Alan ^a   Xavier, Ramnik J ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; ETANERCEPT; GEFITINIB; IMATINIB;

CROHN DISEASE; DIAGNOSTIC PROCEDURE; DISEASE MARKER; EDITORIAL; ENTERITIS; GENE SEQUENCE; GENETIC RISK; INFECTION; MICROORGANISM DETECTION; PHENOTYPE; PRIORITY JOURNAL; ULCERATIVE COLITIS;

EID: 44649168939     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2008.04.013     Document Type: Editorial

References (29)

1. Falkow S. Molecular Koch's postulates applied to microbial pathogenicity. Rev Infect Dis 10 Suppl 2 (1988) S274-S276
2. Taegtmeyer M., Beeching N.J., Scott J., et al. The clinical impact of nucleic acid amplification tests on the diagnosis and management of tuberculosis in a British hospital. Thorax 63 (2008) 317-321
3. Ashworth M., Horan K.L., Freeman R., et al. Use of PCR-based Mycobacterium tuberculosis genotyping to prioritize tuberculosis outbreak control activities. J Clin Microbiol 46 (2008) 856-862
4. Hoek P.K., Gey van Pittius C.N., Moolman-Smook H., et al. Fluorometric assay for susceptibility testing of rifampicin in mycobacterium tuberculosis complex (FAST-Rif). J Clin Microbiol 46 (2008) 1369-1373
5. Yildirim M.A., Goh K.I., Cusick M.E., et al. Drug-target network. Nat Biotechnol 25 (2007) 1119-1126
6. Amarapurkar D.N., Patel N.D., and Rane P.S. Diagnosis of Crohn's disease in India where tuberculosis is widely prevalent. World J Gastroenterol 14 (2008) 741-746
7. Kobayashi K.S., Chamaillard M., Ogura Y., et al. Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract. Science 307 (2005) 731-734
8. Maeda S., Hsu L.C., Liu H., et al. Nod2 mutation in Crohn's disease potentiates NF-kappaB activity and IL-1beta processing. Science 307 (2005) 734-738
9. Hampe J., Franke A., Rosenstiel P., et al. A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1. Nat Genet 39 (2007) 207-211
10. Rioux J.D., Xavier R.J., Taylor K.D., et al. Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis. Nat Genet 39 (2007) 596-604
11. Parkes M., Barrett J.C., Prescott N.J., et al. Sequence variants in the autophagy gene IRGM and multiple other replicating loci contribute to Crohn's disease susceptibility. Nat Genet 39 (2007) 830-832
12. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 447 (2007) 661-678
13. Cho J.H., and Weaver C.T. The genetics of inflammatory bowel disease. Gastroenterology 133 (2007) 1327-1339
14. Teml A., Schaeffeler E., Herrlinger K.R., et al. Thiopurine treatment in inflammatory bowel disease: clinical pharmacology and implication of pharmacogenetically guided dosing. Clin Pharmacokinet 46 (2007) 187-208
15. Daily J.P., Scanfeld D., Pochet N., et al. Distinct physiological states of Plasmodium falciparum in malaria-infected patients. Nature 450 (2007) 1091-1095
16. von Stein P., Lofberg R., Kuznetsov N.V., et al. Multigene analysis can discriminate between ulcerative colitis, Crohn's disease, and irritable bowel syndrome. Gastroenterology 134 (2008) 1869-1881
17. Maresca M., Miller D., Quitard S., et al. Enteropathogenic Escherichia coli (EPEC) effector-mediated suppression of antimicrobial nitric oxide production in a small intestinal epithelial model system. Cell Microbiol 7 (2005) 1749-1762
18. Davis A.S., Vergne I., Master S.S., et al. Mechanism of inducible nitric oxide synthase exclusion from mycobacterial phagosomes. PLoS Pathog 3 (2007) e186
19. Li Q., Park P.W., Wilson C.L., et al. Matrilysin shedding of syndecan-1 regulates chemokine mobilization and transepithelial efflux of neutrophils in acute lung injury. Cell 111 (2002) 635-646
20. Kamarainen M., Heiskala K., Knuutila S., et al. RELP, a novel human REG-like protein with up-regulated expression in inflammatory and metaplastic gastrointestinal mucosa. Am J Pathol 163 (2003) 11-20
21. Lu B., Xu J., Zhu Y., et al. Systemic analysis of the differential gene expression profile in a colonic adenoma-normal SSH library. Clin Chim Acta 378 (2007) 42-47
22. Berruyer C., Pouyet L., Millet V., et al. Vanin-1 licenses inflammatory mediator production by gut epithelial cells and controls colitis by antagonizing peroxisome proliferator-activated receptor gamma activity. J Exp Med 203 (2006) 2817-2827
23. Langhorst J., Elsenbruch S., Koelzer J., et al. Noninvasive markers in the assessment of intestinal inflammation in inflammatory bowel diseases: performance of fecal lactoferrin, calprotectin, and PMN-elastase, CRP, and clinical indices. Am J Gastroenterol 103 (2008) 162-169
24. Frank D.N., and Pace N.R. Gastrointestinal microbiology enters the metagenomics era. Curr Opin Gastroenterol 24 (2008) 4-10
25. Frank D.N., St Amand A.L., Feldman R.A., et al. Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases. Proc Natl Acad Sci U S A 104 (2007) 13780-13785
26. Turnbaugh P.J., Ley R.E., Mahowald M.A., et al. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444 (2006) 1027-1031
27. Dotan I., Fishman S., Dgani Y., et al. Antibodies against laminaribioside and chitobioside are novel serologic markers in Crohn's disease. Gastroenterology 131 (2006) 366-378
28. Annunziato F., Cosmi L., Santarlasci V., et al. Phenotypic and functional features of human Th17 cells. J Exp Med 204 (2007) 1849-1861
29. van Beelen A.J., Zelinkova Z., Taanman-Kueter E.W., et al. Stimulation of the intracellular bacterial sensor NOD2 programs dendritic cells to promote interleukin-17 production in human memory T cells. Immunity 27 (2007) 660-669